Associate Professor Peter Richmond
Third World ear infections in WA children
UWA Associate Professor Peter Richmond, who heads the Vaccine Trials Group based at Perth Children’s Hospital, said more work needed to be done on the bacteria and viruses that caused ear diseases and more research needed to be done into how children develop immunity.Read more
The first line of defence – immunisations
The strongest safeguard against the potentially fatal disease is prevention, and research by the Telethon Kids Institute has helped make immunisation more readily available to the age groups most at risk.Read more
2018 – 2019
Menzies School of Health Research
- CRE Extension Activity - Koorlungkas yarning extention - speech pathology clinic
- Lehmann, D. & Richmond, P.
WA Department of Health
- MHRIF Round 21 - Peter Richmond
- Richmond, P.
Professor Peter Richmond, head of the Vaccine Trials Group, explained the process being used to develop the RSV vaccine was the same as the successful maternal pertussis vaccine, where expectant mothers are vaccinated to increase their antibodies against whooping cough, which they then pass on to their baby.Read more
Head of Telethon Kids’ Vaccine Trials Group, Professor Peter Richmond, said the findings from the Maternal RSV Study have the potential to impact the health of babies on a global scale for years to come.
Head of Telethon Kids’ Vaccine Trials Group, Professor Peter Richmond, said the findings from the Maternal RSV Study have the potential to impact the health of babies on a global scale for years to come.Read more